ASA class is associated with early revision and reoperation after total hip arthroplasty: an analysis of the Geneva and Swedish Hip Arthroplasty Registries.


Journal

Acta orthopaedica
ISSN: 1745-3682
Titre abrégé: Acta Orthop
Pays: Sweden
ID NLM: 101231512

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 1 5 2019
medline: 24 12 2019
entrez: 1 5 2019
Statut: ppublish

Résumé

Background and purpose - Data from several joint replacement registries suggest that the rate of early revision surgery after primary total hip arthroplasty (THA) is increasing. The ASA class, now widely recorded in arthroplasty registries, may predict early revision. We investigated the influence of ASA class on the risk of revision and other reoperation within 3 months and within 5 years of primary THA. Patients and methods - We used data from the Geneva and Swedish Hip Arthroplasty Registries, on primary elective THAs performed in 1996-2016 and 2008-2016, respectively. 5,319 and 122,241 THAs were included, respectively. Outcomes were all-cause revision and other reoperations evaluated using Kaplan-Meier survival and Cox regression analyses. Results - Within 3 months after surgery, higher ASA class was associated with greater risk of revision and other reoperation. 3-month cumulative incidences of revision by ASA class I, II, and III-IV respectively, were 0.6%, 0.7%, and 2.3% in Geneva and 0.5%, 0.8%, and 1.6% in Sweden. 3-month cumulative incidences of other reoperation were 0.4%, 0.7%, and 0.9% in Geneva and 0.2%, 0.4%, and 0.7% in Sweden. Adjusted hazard ratios (ASA III-IV vs. I) for revision within 3 months were 2.7 (95% CI 1.2-5.9) in Geneva and 3.3 (CI 2.6-4.0) in Sweden. Interpretation - Assessment of ASA class of patients prior to THA will facilitate risk stratification. Targeted risk-reduction strategies may be appropriate during the very early postoperative period for patients identified as at higher risk. Systematically recording ASA class in arthroplasty registries will permit risk adjustment and facilitate comparison of revision rates internationally.

Identifiants

pubmed: 31035846
doi: 10.1080/17453674.2019.1605785
pmc: PMC6718172
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

324-330

Références

J Bone Joint Surg Am. 2014 Oct 1;96(19):e167
pubmed: 25274795
J Bone Joint Surg Am. 2012 Jun 20;94(12):1065-70
pubmed: 22717825
BMC Musculoskelet Disord. 2012 Dec 15;13:251
pubmed: 23241396
Health Policy. 2018 May;122(5):548-557
pubmed: 29598886
Anaesth Intensive Care. 2002 Oct;30(5):633-40
pubmed: 12413266
Clin Orthop Relat Res. 2014 Sep;472(9):2779-89
pubmed: 24771260
J Bone Joint Surg Am. 2017 Jan 18;99(2):99-105
pubmed: 28099299
Lancet. 2018 Nov 3;392(10158):1662-1671
pubmed: 30496081
Acta Anaesthesiol Scand. 1997 May;41(5):629-32
pubmed: 9181166
J Orthop Res. 2018 Jan;36(1):432-442
pubmed: 28845900

Auteurs

Rory J Ferguson (RJ)

a Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences , University of Oxford , UK.

Alan J Silman (AJ)

a Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences , University of Oxford , UK.

Christophe Combescure (C)

b Division of Clinical Epidemiology , Geneva University Hospitals , Switzerland.

Erik Bulow (E)

c The Swedish Hip Arthroplasty Register and the Department of Orthopaedics , Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Sweden.

Daniel Odin (D)

c The Swedish Hip Arthroplasty Register and the Department of Orthopaedics , Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Sweden.

Didier Hannouche (D)

d Division of Orthopaedics and Trauma Surgery , Geneva University Hospitals , Switzerland.

Siôn Glyn-Jones (S)

a Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences , University of Oxford , UK.

Ola Rolfson (O)

c The Swedish Hip Arthroplasty Register and the Department of Orthopaedics , Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Sweden.

Anne Lübbeke (A)

a Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences , University of Oxford , UK.
d Division of Orthopaedics and Trauma Surgery , Geneva University Hospitals , Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH